Feds probe Martin Shkreli's alleged prison cellphone use
NEW YORK -- Federal authorities said Friday they are investigating claims that Martin Shkreli has been running his pharmaceutical company from behind bars using a contraband smartphone.
Shkreli, 35, is serving a seven-year sentence for securities fraud at the Federal Correctional Institution at Fort Dix, New Jersey, a low-security prison complex about 40 miles from Philadelphia. He was found guilty of lying to investors in two failed hedge funds and cheating them out of millions. "Like all correctional agencies, the BOP continues to tackle the problem of contraband being introduced into our facilities, including contraband cell phones," the agency said in a statement to The AP."The BOP continually evaluates and deploys as appropriate, contraband-detecting technologies, including walk-through metal detectors and whole-body imaging devices."
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Prison authorities say they are investigating 'pharma bro' ShkreliThe U.S. Bureau of Prisons said on Friday it was investigating former drug compa...
Weiterlesen »
Why Big Pharma Is Diving Into Gene TherapyBarron's cover story: Big Pharma is diving into gene therapy
Weiterlesen »
Exclusive: OxyContin maker Purdue Pharma exploring bankruptcy - sourcesOxyContin maker Purdue Pharma LP is exploring filing for bankruptcy to address p...
Weiterlesen »
Deploying drugs for new purposes holds great promiseRepurposing drugs is a cheaper way of fighting diseases
Weiterlesen »
Exclusive: OxyContin maker Purdue Pharma exploring bankruptcy - sourcesThe deliberations show how Purdue and its wealthy owners, the Sackler family, are under pressure to respond to mounting litigation accusing the pharmaceutical company of misleading doctors and patients about risks associated with prolonged use of its prescription opioids. Purdue denies the allegations
Weiterlesen »
Purdue Pharma says opioid lawsuit by Mass. attorney general amounts to ‘oversimplified scapegoating’The suit alleges that Purdue disregarded safety and pushed doctors to prescribe high doses of OxyContin.
Weiterlesen »
Oxycontin-maker Purdue Pharma reportedly exploring bankruptcy amid litigation over opioidsOxyContin-maker Purdue Pharma is exploring filing for bankruptcy amid thousands of lawsuits alleging the drug manufacturer contributed to the deadly opioid crisis sweeping the US, according to Reuters.
Weiterlesen »
Purdue Pharma seeks dismissal of lawsuit in MassachusettsPurdue Pharma wants a lawsuit dismissed that accuses the company of profiting from the opioid crisis by aggressively marketing OxyContin.
Weiterlesen »
OxyContin maker Purdue Pharma reportedly exploring bankruptcyOxyContin maker Purdue Pharma is exploring filing for bankruptcy to address potentially significant liabilities from thousands of lawsuits, Reuters reports citing people familiar with the matter.
Weiterlesen »